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Sudden cardiac death is responsible for half of all deaths from cardiovascular disease. The 
analysis of the electrophysiological substrate for arrhythmias is crucial for optimal risk 
stratification. A prolonged T-peak-to-end (Tpe) interval on the electrocardiogram is an 
independent predictor of increased arrhythmic risk, and Tpe changes with heart rate are even 
stronger predictors. However, our understanding of the electrophysiological mechanisms 
supporting these risk factors is limited. We conducted genome-wide association studies (GWASs) 
for resting Tpe and Tpe response to exercise and recovery in ~30,000 individuals, followed by 
replication in independent samples (~42,000 for resting Tpe and ~22,000 for Tpe response to 
exercise and recovery), all from UK Biobank. Fifteen and one single-nucleotide variants for resting 
Tpe and Tpe response to exercise, respectively, formally replicated. In a full data set GWAS, 
thirteen further loci for resting Tpe, one for Tpe response to exercise and one for Tpe response 
to exercise were genome-wide significant (P ≤ 5 × 10−8). Sex-specific analyses indicated seven 
additional loci. In total, we identify 32 loci for resting Tpe, three for Tpe response to exercise and 
three for Tpe response to recovery modulating ventricular repolarization, as well as cardiac 
conduction and contraction. Our findings shed light into the genetic basis of resting Tpe and Tpe 
response to exercise and recovery, unveiling plausible candidate genes and biological 









Sudden cardiac death is a leading cause of mortality and is responsible for approximately 
half of all deaths from cardiovascular disease1. Most importantly, the vast majority of sudden 
cardiac deaths occur in the general population without known traditional risk factors2. Guidelines 
exist for preventive strategies, such as insertion of implantable cardioverter defibrillators in high 
risk patient groups3. However, risk stratification is heavily reliant on the assessment of left 
ventricular systolic function, which has low specificity, as opposed to the analysis of the 
electrophysiological substrate for arrhythmias.  
The surface electrocardiogram (ECG) is a widely available non-invasive tool, which 
provides a rapid assessment of underlying cardiac electrophysiology and is therefore a useful 
method to infer arrhythmic risk. An abnormally prolonged Tpeak-to-Tend (Tpe) interval on the 
ECG is a risk factor for ventricular arrhythmic mortality and all-cause mortality, independent of 
age, sex, comorbidities, QRS duration and corrected QT interval (MIM 610141), not only in 
healthy subjects4, but also individuals with acquired QT prolongation5; 6 and cardiac patients7-12. 
In addition, the response of the Tpe interval to heart rate has also been reported to be significantly 
associated with sudden cardiac death in patients with heart failure13; 14. 
Although the general view is that the Tpe interval and the T-wave more commonly reflect 
spatial dispersion of repolarisation in different regions of the heart, the exact nature of this is 
disputed15-17. One pre-eminent suggestion is that it reflects differences in transmural 
repolarisation, but this is largely based on the ex-vivo ventricular wedge preparation and has not 
been reproduced in the intact heart16; 18; 19. Thus, novel approaches are needed to improve our 




Prior work in twin studies has demonstrated that resting Tpe interval is heritable (52% - 
63%)20 and, consequently, genetic analyses have been undertaken to uncover its genetic 
determinants, identifying five loci21; 22 (Table S1). However, no genome-wide association study 
(GWAS) has been performed for resting Tpe interval in relatively large cohorts (> 6,000 
individuals) and the genetic basis of Tpe response to exercise and to recovery has never been 
studied.  
Our objective was to identify genetic variants significantly associated with three traits 
(Figure 1) in a large middle-aged population from the UK: (1) Resting Tpe interval (N = 71,338), 
(2) Tpe response to exercise (N = 51,897) and (3) Tpe response to recovery (N = 51,503). We 
applied extensive bioinformatics analyses to investigate the main biological pathways linking the 
identified loci and the three traits. 
 
Materials and Methods  
Anonymized data and materials have been returned to UK Biobank (UKB) and can be accessed 
per request. 
UK Biobank 
UKB is a prospective study of 488,377 volunteers comprising relatively even numbers of 
men and women aged 40-69 years old at recruitment (2006-2008). The UKB study has approval 
from the North West Multi-Centre Research Ethics Committee, and all participants provided 
informed consent23. The work was undertaken as part of UKB application 8256. 
Genotyping was performed by UKB using the Applied Biosystems UK BiLEVE Axiom 
Array or the UKB AxiomTM Array24. Single nucleotide variants (SNVs) were imputed centrally by 
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UKB using the Haplotype Reference Consortium (HRC) and the 1000 Genomes Project (1000G) 
reference panels. Information on UKB array design and protocols is available on the UKB website 
(URLs). 
Participants were genotyped using a customised array (including GWAS and exome 
content) and with genome-wide imputation based on HRC and 1000G sequencing data25. A sub 
cohort of 58,839 individuals completed an exercise test using a stationary bicycle in conjunction 
with an ECG recording (lead I, 2009, EST-UKB cohort). In parallel, a sub cohort of 35,225 
individuals participated in an imaging study (05/2014-03/2019 – the collection is ongoing, IMAGE-
UKB), which included 10 seconds 12-lead ECG recordings. All ECGs were acquired following the 
same protocol (see UKB website in URLs) and analysed with the methods explained below. 
Phenotypic and genetic QC 
 Detailed information about the phenotypic and genetic quality control (QC) are indicated 
in Figure S1 and Supplemental Methods. Of the 56,385 individuals from EST-UKB who passed 
the phenotypic QC, 52,147 complied with genetic QC and were of European ancestry. Similarly, 
of the 26,467 individuals from IMAGE-UKB who passed the phenotypic QC, 24,999 complied with 
genetic QC and were of European ancestry. Then, 5,569 individuals who were in both the EST-
UKB and IMAGE-UKB cohorts were excluded from the IMAGE-UKB cohort. After exclusions, 
there were 52,147 individuals from the EST-UKB cohort and 19,430 individuals from the IMAGE-
UKB cohort available for genetic analyses (Figure S1). 
Derivation of resting Tpe and Tpe response to exercise and recovery from the EST-UKB cohort 
 The bicycle ergometer test followed a standardized protocol of 15 seconds resting period, 
followed by 6 minutes of exercise during which the workload was gradually increased, and a 1-
minute recovery period without pedalling. Pre-processing of the ECG signals from the EST-UKB 
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cohort included low-pass filtering at 50 Hz to remove electric and muscle noise but still allow QRS 
detection26. Baseline wander was removed by further high-pass filtering the ECG signals at 0.5 
Hz. Automatic quantification of resting Tpe and Tpe response to exercise and recovery (shown in 
Figure 1) was performed on every ECG recording in three steps:  
(1) We signal-averaged the heartbeats within a window of 15 seconds during rest (black), at 
peak exercise (red), and 50 seconds after peak exercise (blue) to attenuate noise and 
artefacts and reveal small variations in the QRS-T-waveform. The onset, peak and offset 
timings of the waveforms were located using bespoke software16; 27.  
(2) We derived resting, peak exercise and recovery Tpe intervals as the temporal differences 
between the corresponding T-wave end and T-wave peak timing locations. 
(3) Tpe response to exercise was derived by quantifying the difference between the Tpe 
intervals at rest (black T-wave) and at peak exercise (red T-wave), normalized by the RR 
change during this interval, 𝛥𝑅𝑅𝑒𝑥. Similarly, Tpe response to recovery was derived by 
quantifying the difference between the Tpe intervals at peak exercise (red T-wave) and 
full recovery (blue T-wave), normalized by the subsequent RR change, 𝛥𝑅𝑅𝑟𝑒𝑐. 
Derivation of resting Tpe from the IMAGE-UKB cohort 
We chose lead I for analysis in the IMAGE-UKB cohort to match the EST-UKB signal. We 
removed baseline wander using a publicly available algorithm (see URLs). We pre-processed and 
signal averaged the heartbeats in the 10-second recordings as in the EST-UKB cohort. The onset, 
peak and end timings of the waveforms were located using the same bespoke software as in 
previous studies16; 27. Resting Tpe was derived as the temporal difference between the T-wave 
end and the T-wave peak timing locations. 
For resting Tpe, we pooled the measurements from both EST-UKB and IMAGE-UKB 
cohorts together, leading to 71,338 individuals with resting Tpe. Inverse-normal transformation of 
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resting Tpe and Tpe response to exercise and recovery was performed, as the distributions were 
skewed (Figure 2). 
Genetic analyses 
An overview of the study design is provided in Figure 3. We randomly divided our cleaned 
data sets into discovery (N ~ 30,000) and replication (N ~ 42,000 for resting Tpe and N ~ 22,000 
for Tpe response to exercise and to recovery) datasets.  To ensure that there was no overlap 
across datasets, we removed first- and second-degree related individuals (kinship coefficient > 
0.88) from the replication cohort as indicated from UKB24. We next selected model SNVs from 
directly genotyped SNVs using PLINK 1.928. This selection was based on the following criteria: 
minor allele frequency (MAF) > 5%, a Hardy-Weinberg equilibrium with a threshold of P-value = 
1 x 10-6, and missingness < 0.0015. Model SNVs are used to learn the parameters from the mixed 
models for both the heritability estimation and the GWASs (see below).  
Then, we estimated the proportion of resting Tpe, and Tpe response to exercise and 
recovery explained by additive genetic variation (heritability), as well as their genetic correlation 
with each other, using a variance components method (BOLT-REML)29, with the model SNVs and 
~ 9 million imputed variants with MAF ≥ 1% and INFO > 0.3 using the full cohorts (Figure 3).  
Next, we performed a GWAS for each trait using a linear mixed model method (BOLT-
LMM)30 under the additive genetic model, including the model SNVs and ~9 million imputed SNVs 
with MAF ≥ 1% and INFO > 0.3 in the discovery dataset (Figure 3). For resting Tpe, we included 
the following covariates (details can be found in the Supplemental Methods): sex, age, body mass 
index (BMI), smoking status, resting RR, and a binary indicator variable for the genotyping array 
(UKB versus UK BiLEVE). For Tpe response to exercise, we included sex, age, BMI, diabetic 
status, resting RR, 𝛥𝑅𝑅𝑒𝑥 and the genetic array. For Tpe response to recovery, we included sex, 




All SNVs with P < 1 x 10-6 from the discovery GWAS for each trait were compiled and 
mapped to individual loci based on a genomic distance of > 500 Kb to each side of another SNV. 
If multiple SNVs fitted the selection criteria for a single region, only the SNV with the smallest P-
value was taken forward into replication. As a QC step, we reviewed each selected SNV to check 
for unrealistically high effect sizes or large standard errors, and none were observed. Regional 
plots were produced for all selected SNVs and these were carefully reviewed. Twenty-one 
variants for resting Tpe, 4 variants for Tpe response to exercise and 7 variants for Tpe response 
to recovery were taken forward into replication. Replication was confirmed if P ≤ 0.05/21 = 2.4 × 
10−3 for resting Tpe, P ≤ 0.05/4 = 1.3 × 10−2 for Tpe response to exercise and P ≤ 0.05/7 = 7.1 × 
10−3 for Tpe response to recovery and the effect was in the direction observed in discovery 
analyses for each trait in the replication cohort (Figure 3).  
Full data set analyses 
In addition to the two-stage study design of discovery and replication cohorts, we also 
conducted a full data set GWAS including all individuals (N = 71,338 for resting Tpe and N = 
51,897 for Tpe response to exercise and N = 51,503 for Tpe response to recovery) using BOLT-
LMM30. Additional loci for each trait reaching a genome-wide significance threshold (P ≤ 5 × 10−8) 
from the full data set GWAS are reported (Figure 3). To test for polygenicity, any underlying 
residual population stratification or QC factors affecting our GWAS results, we run LD Score 
Regression31. 
Conditional analyses 
To examine if there were independent SNVs at these loci, we applied genome-wide 
complex trait analysis32. We declared a secondary signal if: (i) the identified SNV original P value 
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was lower than 1x10-6; (ii) there was less than a 1.5-fold difference between the lead SNV and 
secondary association P values on a –log10 scale, i.e., if –log10(Plead)/-log10(Psec) < 1.5; and (iii) if 
there was less than a 1.5-fold difference between the main association and conditional 
association P values on a –log10 scale, i.e., if –log10(Psec)/-log10(Pcond) < 1.533.  
Sex-stratified analyses 
For each trait, we performed a GWAS for men and women separately in the full cohort 
including the same covariates in the regression model as specified above, but excluding sex 
(Figure 3). 
Per cent variance explained 
 The per cent variance explained of each variant was calculated by estimating the residuals 
from the regression model against the covariates used in each respective genetic model. We then 
fitted a second linear model for the trait residuals with all the identified variants plus the top ten 
principal components. The per cent variance explained was the difference between the adjusted 
R-squared parameters from each model33. 
Bioinformatics analyses 
We performed several analyses to annotate the identified SNVs, at the variant and gene 
level (all SNVs in linkage disequilibrium (LD), r2 ≥ 0.8 with the traits associated SNVs were 
considered). LD was calculated using genetic data from UKB in order to calculate pairwise-LD for 
all associated SNVs. The r2 of pairwise SNVs (minimum r2 = 0.8 and maximum distance between 
a pair of SNVs is 4 Mb) were computed using PLINK28.  
Using the University of California, Santa Cruz known genes, we annotated each lead SNV 
with the nearest coding genes and those located within 50 kb. At the variant level, we used Variant 
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Effect Predictor34 to obtain comprehensive functional characterization of variants, including their 
gene location, conservation, and amino acid substitution impact based on a range of prediction 
tools including SIFT and PolyPhen-2.  
We evaluated all SNVs in LD (r2 ≥ 0.8) with our validated lead SNVs for evidence of 
mediation of expression quantitative trait loci (eQTL) using the GTEx database, focusing on loci 
with the strongest evidence of eQTL associations in brain, heart and adrenal tissue. We also 
performed colocalisation analyses using COLOC35 including all SNVs within all loci with evidence 
of eQTLs in the relevant tissues, and analysed each eQTL-GWAS dataset pair. This tool is based 
on a Bayesian statistical methodology that tests pairwise colocalisation of SNVs in GWAS with 
eQTLs and generates posterior probabilities for each locus weighting the evidence for competing 
hypothesis of either no colocalisation or sharing of a distinct SNV at each locus. A posterior 
probability of ≥ 75% was considered strong evidence of the tissue-specific eQTL-GWAS pair 
influencing both the expression and GWAS trait at a particular region. We, then, identified variants 
with regulatory potential using RegulomeDB36 and found genes whose promoter regions form 
significant chromatin interaction with them from a range of tissues, including brain, heart and 
adrenal long-range chromatin interaction (Hi-C) data. We found the most significant promoter 
interactions for all potential regulatory SNVs (RegulomeDB score ≤ 5) in LD (r2 ≥ 0.8) with our 
sentinel SNVs and chose the interactors with the SNVs of highest regulatory potential to annotate 
the loci. 
We also performed enrichment testing across all loci. We used DEPICT37 to identify cells 
and tissues in which resting Tpe and Tpe response to exercise and to recovery loci were highly 
expressed. Due to the limited number of identified loci for Tpe response to exercise and to 
recovery, we used g:profiler38 to perform functional profiling of gene lists using various kinds of 
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biological evidence (including GO, HPO annotation). Enrichment results with false discovery 
rate<5% were deemed significant. 
Furthermore, to systematically characterize the functional, cellular, and regulatory 
contribution of genetic variation, we used GARFIELD39, analysing the enrichment of genome-wide 
association summary statistics in tissue-specific functional elements at given significance 
thresholds. 
The National Center for Biotechnology Information (NCBI) Gene database and 
GeneCards®: The Human Gene Database were used to obtain official full names and, where 
relevant, common aliases for each candidate gene product. NCBI’s PubMed was used to 
interrogate primary literature pertaining to gene function. We also reviewed gene-specific animal 
models using International Mouse Phenotyping Consortium40 and the Mouse Genome Informatics 
database. 
Finally, to explore shared mechanisms of disease, we assessed association of our 
identified SNVs (and their proxies, r2 ≥ 0.8) with other traits from published GWAS using 
PhenoScanner41. Our group has recently performed GWASs on the PR interval (MIM 108980)42 
and on two traits related to the Tpe interval, T-wave morphology restitution during exercise and 
during recovery43, but results are not yet available in PhenoScanner or GWAS Catalog. In 
addition, a recent paper also still not in PhenoScanner or GWAS Catalog reported genetic variants 
significantly associated with the QRS complex44. We, therefore, performed a lookup of the 
reported lead SNVs in our results to check for pleiotropy. 
Genetic risk score analyses 
To evaluate the impact of a genetically prolonged Tpe interval on ventricular arrhythmic 
risk (definition can be found in Table S2 and in the Supplemental Methods), we split all remaining 
individuals from UKB into training (N = 274,256, 0.6% arrhythmic events) and validation (N = 
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68,563, 0.6% arrhythmic events) subsets. These were unrelated UKB individuals of European 
ancestry not included in the EST-UKB and IMAGE-UKB cohorts, who passed genetic QC, were 
free of a previous history of CV events, and were unrelated (FULL-UKB, Figure S2). This split 
was random, but we ensured a similar prevalence of events across both subsets. We obtained 
the optimal P-value cut-off for the GRS using PRSice v245 in the training subset (Supplemental 
Methods). We then applied logistic regression to test for an association between the GRS derived 
with the optimal P-value cut-off and ventricular arrhythmic risk in the validation set. 
 
Results 
 The median (interquartile range) values of resting Tpe in both the EST-UKB and the 
IMAGE-UKB cohorts was 62 (12) ms (Figure S3). Histograms showing the distribution of the three 
traits are provided in Figure 2. The heritability estimate of resting Tpe was 15.6%, and its genetic 
correlations were 0.30 with Tpe response to exercise and 0.11 with Tpe response to recovery. 
The heritability estimates of the Tpe responses to exercise and to recovery were relatively low, 
2.2% and 2.4%, respectively, and their genetic correlation to each other was 0.55. 
Twenty-eight genetic loci are associated with resting Tpe 
In the discovery GWAS for resting Tpe, 12 loci were genome-wide significant (P ≤ 5 x 10-
8, Table S3). Using a significance threshold of P < 1 x 10-6, 21 variants (considering one lead SNV 
per 1Mb region) were identified as significant and taken forward into replication in ~42,000 
independent samples from UKB. Fifteen of the 21 selected SNVs for resting Tpe formally 
replicated (P ≤ 0.05/21 = 2.4 x 10-3) and all had concordant directions of effect (Table 1). 
Thirteen additional SNVs (also considering one lead SNV per 1 Mb region) reached 
genome-wide significance in the full dataset GWAS, all with concordant directions of effect across 
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discovery, validation and full cohort datasets (Table 1). Manhattan plots in the full dataset GWAS 
results are shown in Figure S4A, and QQ plots including the discovery (blue) and full dataset 
(black) GWASs are shown in Figure S5. The intercept of the LD Score Regression31 was 1.005 
(standard error of 0.0097), indicating inflation of the lambdas is predominantly due to polygenicity, 
and not to underlying QC factors, or population stratification. Regional plots are shown in Figure 
S6. 
Conditional analyses showed evidence for four secondary independent signals at loci DPT 
(MIM 125597), SCN5A-SCN10A (MIM 600163) and LITAF (MIM 603795, Table 1, Figure S7). 
The secondary signal at DPT, rs761499672, was located 379 Kb away from the lead SNV, 
rs607484; while the secondary signals at SCN5A-SCN10A, rs6797133 and rs6801957, were 
located 54 Kb and 57 Kb, respectively, away from the lead SNV (rs7373065). Finally, the 
secondary signal at LITAF, rs570620219, was located 40 Kb away from the lead SNV 
(rs2080512). 
Taken together, across both the replication stage and full data set GWAS, we identified 
32 SNVs (28 lead SNVs + 4 secondary SNVs) in 28 loci for resting Tpe (Figure 3 and Table 1), 
which explained 3.20% of its variance. This corresponds to ~21% of its estimated heritability. 
Three genetic loci are associated with the Tpe response to exercise and recovery 
For Tpe response to exercise and to recovery traits, no genome-wide significant loci were 
found in the discovery cohorts. Four and seven variants for each Tpe response trait met our pre-
defined threshold of P < 10-6 to take forward into replication in ~22,000 independent samples. 
One of the selected SNVs for Tpe response to exercise formally replicated (P ≤ 0.05/4 = 0.0125) 
and had concordant directions of effect in discovery and replication datasets (Table 2). None of 
the seven SNVs for Tpe response to recovery that were taken forward into replication formally 
replicated (Table 3). 
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One additional SNV reached genome-wide significance in the full data set GWAS for each 
Tpe response trait, all with concordant directions of effect across discovery and replication 
datasets (Tables 2 and 3). Manhattan plots for the full dataset GWAS results are shown in Figures 
S4B and S4C, and QQ plots including the discovery (blue) and full dataset (black) GWASs are 
shown in Figure S5, where the value of the lambdas suggests there was minimal inflation. 
Regional plots are shown in Figures S8 and S9. We performed conditional analyses and no 
independent signals were found at any of the identified loci. 
In total, across both the replication stage and full data set GWAS, we identified two loci 
for Tpe response to exercise, which explained 0.16% of its variance, and one for Tpe response 
to recovery, which explained 0.06% of its variance (Figure 3 and Tables 2 and 3). Of note, the 
one locus identified for Tpe response to recovery did not overlap with resting Tpe interval or Tpe 
response to exercise (Figure 4). 
Four male-specific loci for resting Tpe and three for Tpe response to exercise and recovery 
We identified variants associated with resting Tpe in males at four additional loci: FAAP20 
(MIM 615183), GPR1 (MIM 600239), HEY2 (MIM 604674) and LIG3 (MIM 600940). Variants at 
these loci were not significant (P > 5 x 10-8) in the combined analyses (Table S4A, Figure S10). 
For Tpe response to exercise, we identified one variant at the ETS2 locus (MIM 164740) for males 
(N = 24,241). This variant was non-significant in the combined sex GWAS (Table S4B, Figure 
S11). Finally, for Tpe response to recovery, we identified two female-specific variants at loci 
NRXN3 (MIM 600567) and NOL4L (Table S4C, Figure S12). 
Bioinformatics for resting Tpe loci 
None of the lead variants or their close proxies (r2 > 0.8) for resting Tpe were annotated 
as missense variants. However, we identified regulatory variants that might affect gene 
16 
 
expression levels of their target genes in heart and brain tissue by interrogating publicly available 
eQTL datasets using GTEx (see URLs). Nine lead variants associated with resting Tpe (at SSBP3 
[MIM 607390], SGIP1 [MIM 611540], NKX2-5 [MIM 600584], HEY2, MSRA [MIM 601250], IGF1R 
[MIM 147370], LITAF, GINS3 [MIM 610610] and LIG3) were in high LD (r2 > 0.8) with top eQTL 
variants in cardiac and brain tissue (Table S5). We found strong support for pairwise 
colocalisation of SNVs in GWAS with eQTLs at five genes (SSBP3, SGIP1, IGF1R, LITAF and 
LIG3) in cardiac left ventricle, three genes (SSBP3, NDRG4 [MIM 614463] and LIG3) in cardiac 
atrial appendages and three genes (NKX2-5, RP11-481J2.2 and LIG3) in brain tissue (Table S5). 
We next identified 34 potential target genes at 15 resting Tpe loci whose promoter regions 
form significant chromatin interactions in brain and heart using publicly available Hi-C data (Table 
S6A). 
These results were used to prepare a list of potential candidate genes for each identified 
locus for resting Tpe (Table S7A). 
Enriched tissues, gene sets and pathways for resting Tpe loci 
We observed a significant enrichment of resting Tpe loci in heart tissue (Figure S13). By 
considering all identified loci, our DEPICT analyses identified enrichment of expression in the 
heart, in the ventricles and in the atria, with the greatest enrichment in the heart (P = 1.87 x 10-4, 
false discovery rate < 0.01, Table S8). We also observed significant enrichments (a false 
discovery rate < 0.05) in 17 gene sets from the Gene Ontology, 15 from the Mouse Phenotype 
Ontology, 54 from ENSEMBL and 3 from Kyoto encyclopedia of genes and genomes. The most 
significant enrichments were negative regulation of transport (P = 2.26 x 10-6) from the Gene 
Ontology, increased infarction size (P = 4.04 x 10-6) from the Mouse Phenotype Ontology, the 
NOS3 PPI subnetwork (P = 2.62 x 10-9) from ENSEMBL and regulation of actin cytoskeleton (P 
= 1 x 10-4) from Kyoto encyclopedia of genes and genomes (Tables S9A, S9B, S9C and S9D). 
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Bioinformatics analyses of the Tpe response to exercise and recovery loci 
None of the lead variants for Tpe response to exercise or to recovery or their close proxies 
(r2 > 0.8) were annotated as missense variants or were identified as regulatory variants that might 
affect gene expression levels of their target genes in heart and brain tissue. 
We identified the genes ETS2 for Tpe response to exercise and KIK3B (MIM 603754) for 
Tpe response to recovery whose promoter regions formed significant chromatin interactions with 
them in the left ventricle (Tables S6B and S6C). There were no significant results from DEPICT 
analyses, therefore we performed pathway analyses using g:profiler38 including only nearest 
genes or candidate genes indicated from long-range interaction results (Tables S7B and S7C). 
The top enriched pathways for Tpe response to exercise were regulation of skeletal muscle 
contraction by action potential (P = 3.77 x 10-2) and regulation of skeletal muscle contraction via 
regulation of action potential (P = 3.77 x 10-2, Figure S14). We did not observe any significant 
biological process for the candidate genes for Tpe response to recovery. 
Association of resting Tpe and Tpe response to exercise and to recovery loci with other traits 
SNVs at 13 loci for resting Tpe had previously been associated (P < 5 x 10-8) with other 
traits, including pulse rate, P-wave duration, resting heart rate (MIM 607276), QT interval, QRS 
duration, cardiomegaly, Brugada syndrome (MIM 601144), and atrial fibrillation (MIM 608583, 
Table S10). Variants at two loci (SSBP3 and DPT) for the PR interval, at four loci (KCND3 [MIM 
605411], MEF2D [MIM 600663], CAMK2D [MIM 607708] and LITAF) and at five loci (SSBP3, 
SCN5A-SCN10A, CAMK2D, KCNH2 [MIM 152427] and KCNJ2 [MIM 600681]) for the T-wave 
morphology restitution were genome-wide significant in our results (Table S11).  
An overview of loci for resting Tpe and Tpe response to exercise and to recovery with 
other ECG traits is indicated by a Venn diagram in Figure 4. Interestingly, the loci for Tpe response 
18 
 
to exercise and to recovery did not overlap with other ECG traits, except for the KCNJ2 locus 
associated with Tpe response to exercise. This locus has also been associated with resting Tpe. 
It should be noted, however, that both lead SNVs were not in high LD (r2 = 0.56, Tables 1 and 2).  
 Genetic risk score for resting Tpe 
 The optimal P-value cut-off in the training set was P = 0.012 (Figure S15, 12,107 SNVs). 
The GRS was not significantly associated with arrhythmic events in the validation subset (P = 
0.13, Figure S15). 
 
Discussion 
This is the largest study to date studying the genetic contribution to the Tpe interval, and 
Tpe response to exercise and recovery. With the unique combination of a robust framework, 
including independent discovery and replication samples, and dense genetic imputation in 
~72,000 individuals25, we identified twenty-eight loci and four male-specific loci for resting Tpe, 
ten of which are specific to resting Tpe. We also identified three loci for Tpe response to exercise 
(one male-specific locus) and three loci for Tpe response to recovery (two female-specific loci). 
One locus (KCNJ2) for the Tpe response to exercise had previously been associated with other 
ECG traits including resting Tpe. The main biological processes indicated for resting Tpe involved 
ventricular repolarization and cardiac conduction and contraction. 
Ten of the total 32 loci discovered in this work (four validated, four identified in the full 
dataset GWAS, and two male-specific) did not overlap with any locus previously reported for 
another ECG trait (PRAG1 [MIM 617344], PYGB [MIM 138550], CREB5 [MIM 618262], KCNJ4 
[MIM 600504], MSRA, RUFY1 [MIM 610327], SERTAD2 [MIM 617851], DEFB118 [MIM 607650], 
GPR1, and HEY2, respectively, Figure 4). Twelve of the remaining loci (eleven lead and one 
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male-specific) were associated with resting QT interval. Two additional loci were associated with 
resting heart rate, five with QRS complex and three (two lead and one male-specific) with PR 
interval (Figure 4). These observations underline, as expected, shared genetics among ECG 
traits, but importantly we also observed specific Tpe loci.  
Of the ten resting Tpe specific loci, a summation of bioinformatics analyses and literature 
review indicated eight loci (PRAG1, PYGB, KCNJ4, MSRA, RUFY1, SERTAD2, GPR1 and HEY2) 
had plausible candidate genes (PPP1R3B/MFHAS1 [MIM 610541/605352], PYGB, KCNJ4, 
GATA4 [MIM 600576], RUFY1, SERTAD2, GPR1/ZDBF2 [MIM 617059] and HEY2, Table S7A). 
From the candidate genes at validated loci, PYGB encodes a glycogen phosphorylase (GP) that 
is found in the heart. The physiological role of myocardial GP is to provide the energy supply 
required for myocardial contraction and it is associated with diseases including myocardial 
infarction (MIM 608446)46. A second candidate gene, KCNJ4 functions closely with KCNJ2 (also 
identified in this work). Both genes encode the human inward rectifier potassium channels Kir2.1 
and Kir2.3. These potassium selective ion channels determine the resting membrane potential 
and terminal repolarisation of the cardiac action potential. Importantly, mutations in KCNJ4 are 
associated with electrolyte imbalance and dilated cardiomyopathy (MIM 115200)47. From the 
candidate genes identified from the full dataset GWAS, GATA4, a candidate gene at locus MSRA, 
plays a key role in cardiac development and function48. In co-operation with TBX5 (MIM 601620), 
it binds to cardiac super-enhancers and promotes cardiomyocyte gene expression, while it 
downregulates endocardial and endothelial gene expression48. Mutations in this gene have been 
associated with cardiac septal defects49; 50, tetralogy of Fallot (MIM 187500)51, cardiac myocyte 
enlargement52 and atrial fibrillation53. Finally, from the candidate genes identified in sex-specific 
analyses, HEY2 encodes a member of the hairy and enhancer of split-related family of 
transcription factors. Two similar and redundant genes in the mouse are required for embryonic 
cardiovascular development. Interestingly, the lead variant we have identified at this locus, 
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rs10457469 is in high LD (r2 = 0.97) with rs9388451, which has been reported to be associated 
with Brugada Syndrome through a HEY2-dependent alteration of ion channel expression across 
the cardiac ventricular wall54. Interestingly, HEY2 represses transcription by the cardiac 
transcriptional activators GATA4 and GATA6 (MIM 601656)55.  
Bioinformatics analyses on all loci identified in this study indicate that the main biological 
mechanism underlying resting Tpe is predominantly driven by cellular processes that control 
ventricular repolarisation. As highlighted above, KCNJ2 and KCNJ4 are resting Tpe-specific 
candidate genes involved in ventricular repolarization. In particular, the SNV rs4399570, mapping 
to KCNJ2, demonstrated the strongest association with resting Tpe (P = 5.30 x 10-143) and has 
one of the largest effect sizes for this trait (1.30 ms). Mutations in KCNJ2 are associated with 
Short QT syndrome 3 (MIM 609622)56 and cardiac arrhythmias57; 58. In addition, we identified 
variants at KCNH2 and RNF207 (MIM 616923), both loci previously associated with the QT 
interval59. KCNH2 is another important gene that encodes a crucial potassium repolarising 
current, HERG. Finally, RNF207, a RING finger protein, is a known modulator of cardiac 
repolarisation through actions on HERG60. These four loci were validated in our work. 
An additional biological mechanism underlying resting Tpe is cardiac conduction and 
contraction. Several candidate genes, such as PYGB, GATA4 and HEY2 (highlighted before), as 
well as previously reported SCN5A-SCN10A, CAMK2D and KCND3 are involved. CAMK2D is the 
candidate gene at the validated locus CAMK2D and is a calcium/calmodulin-dependent protein 
kinase involved in the excitation-contraction coupling in heart by targeting Ca(2+) influx into the 
myocyte. KCND3 is the candidate gene at locus KCND3, discovered in the full dataset GWAS, 
and encodes the Ito carrying KV4.3 channel, and gain-of-function mutations have been 
associated with Brugada syndrome61 and atrial fibrillation62. Recent studies have suggested that 
an increased KV4.3 expression modulates NaV1.5 sodium current, resulting in a loss of 
21 
 
conduction63. A possible biological mechanism linking ventricular repolarization and cardiac 
contraction is cardiac mechano-electric coupling, by which myocardial deformation causes 
changes in cardiac electrophysiological parameters64; 65 and mechanosensitive ion channels 
modulate ventricular repolarisation during ventricular contraction.  
Our work significantly expands previous literature on the genetic architecture of the Tpe 
interval. A previous study21 on this topic examined the relationship of seven SNVs previously 
associated with the QT interval to the Tpe interval in 5,890 individuals, two SNVs at KCNH2 were 
genome-wide significant in our results (Table S1). The second study22 performed a GWAS for 
resting Tpe interval on 1,870 individuals. They discovered and validated a strong signal (P = 1.1 
x 10-10), at KCNJ2, a locus which was also highly significant in our results (P = 4.2 x 10-148). 
However, their reported suggestive SNV, rs17749681, at GRIN2A (MIM 138253), was non-
significant in our results (Table S1). 
The identified loci for Tpe response to exercise and Tpe response to recovery are 
potentially interesting as there was almost no overlap between traits, with resting Tpe or with other 
ECG traits. To highlight one of the candidate genes for Tpe response to exercise, ETS2, mapping 
the male-specific locus ETS2, plays an important role in a genetic network that governs 
cardiopoiesis66. It has been shown that variations in ETS2 abundance in hearts of adult rodents 
and the associated loss of cardiomyocytes contribute to the longevity variability observed during 
normal aging of rats through activation of programmed necrosis67. In the development of a 
functional myocardium and formation of the coronary vasculature, epicardially-derived cells play 
an essential role, and ETS2 was found to be essential for normal coronary and myocardial 
development in chicken embryos68. 
In this study, the number of identified SNVs for Tpe response to exercise and to recovery 
was limited, and this might be partly due to the low heritability of the traits (2.2% for Tpe response 
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during exercise and 2.4% for Tpe response during recovery). Our data suggests there is a 
significant genetic contribution to resting Tpe, but its response to heart rate changes is mainly 
influenced by environmental factors. This is a general feature that is emerging from our studies, 
namely that the heritability of exercise-induced changes in cardiac electrophysiology is lower than 
those at rest43; 69. Interventions such as exercise training may therefore have an impact on 
ventricular repolarization and, thus, reduce its associated risk. 
Our sex-specific findings strengthen previous studies concluding that there are sex 
differences in the resting Tpe and its response to heart rate13; 70-72. Therefore, genetics might be 
playing a role in the modulation of cardiac electrical activity in addition to sex hormones, with men 
having a greater genetic influence compared to women. 
Despite finding a significant association between the GRS and ventricular arrhythmic 
events in a training cohort, this significance was not validated in an independent subset of 
individuals. This might indicate that the common variants modulating resting Tpe do not contribute 
to the pathophysiological mechanisms influencing ventricular arrhythmic risk. Alternatively, given 
the low incidence of arrhythmic events in the UK Biobank, which comprises a relatively healthy 
population, the validation analysis might have been underpowered. Future studies should 
evaluate the prognostic value of the GRS in well-powered cohorts for validation of our negative 
results. 
Our study has some limitations. First, we report results from GWASs including all available 
samples, which indicate seven loci for resting Tpe, two for Tpe response to exercise and three 
loci for Tpe response to recovery with no independent replication, so these loci should be 
considered as preliminary until they are externally validated. Next, due to the relatively low sample 
size, we restricted our analysis to common variants (MAF > 1%), so we are unable to comment 
on the role of rare variants on the Tpe traits. In addition, we only report results for European 
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ancestry as this was by far the largest ancestral group in the UKB cohort. Additional studies will 
need to investigate whether the findings can be extrapolated to other ancestries. Finally, the range 
of variation of the Tpe response to exercise and recovery traits is small, and the limited sampling 
rate of the ECG recordings (500 Hz), corresponding to a temporal resolution of 2 ms, might have 
hindered the resolution of these measurements. 
 In summary, our findings provide additional loci for Tpe interval traits and reveal the role 
of ventricular repolarization and cardiac conduction and contraction in modulating them. Our work 
may guide future studies identifying new therapeutic targets to modulate resting Tpe and its 
dynamics to prevent and treat ventricular arrhythmias. 
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Figure 1: Assessment of Tpe indices in the EST-UKB cohort.  
(Top) Illustration of the RR profile during the exercise stress test. (Bottom) Three averaged heartbeats are 
derived at rest (black filled circle), peak exercise (red filled circle) and full recovery (blue filled circle), 
respectively. Resting, peak exercise and recovery Tpe intervals were derived as the temporal differences 
between the corresponding T-wave offset and T-wave peak timing locations. Tpe dynamics during exercise 
was derived by quantifying the difference between the Tpe intervals at rest (black T-wave) and at peak 
exercise (red T-wave), normalised by the RR change during this interval. Similarly, Tpe dynamics during 
recovery was derived by quantifying the difference between the Tpe intervals at peak exercise (red T-







Figure 2: Density plots of Tpe phenotypes. 
Resting Tpe (A), Tpe dynamics during exercise (B) and Tpe dynamics during recovery (C). The blue curves 





















Figure 3: Analytical 5-stage approach flowchart.  











Figure 4: Overlap of resting Tpe, Tpe response to exercise and Tpe response to recovery loci with other 
electrocardiogram traits.  
SNVs at loci with a known genome-wide significant association (from PhenoScanner or GWAS catalogue) 
with other ECG traits are grouped accordingly. The locus names indicate the nearest coding genes. The 
KCNJ2 locus was shared between resting Tpe and Tpe dynamics during exercise. There was no loci overlap 
between Tpe response to recovery and resting Tpe or Tpe response to exercise. There was a substantial 
number of loci for resting Tpe that did not overlap with other ECG traits.  
Underlined loci are loci that have previously been associated with other ECG markers but the reported 
variant was not in high LD (r2 < 0.8) with our lead variant, so potentially independent signals at those loci.  
Bold loci are loci that have not been associated with other ECG marker.  
† indicates sex-specific loci.  



























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 1: Discovery, replication and full GWAS results for the lead SNVs for resting Tpe 
interval. Abbreviations: SNV: single-nucleotide variation, CHR: Chromosome, BP: Position, 
based on HG build 19, EA: Effect allele, AA: Alternate allele, EAF: Effect allele frequency from 
40 
 
discovery data, β: Beta, SE: Standard Error, N: number of participants, P: P-value. The locus 
name indicates the gene that is in the closest proximity to the most associated SNV. Replicated 
SNVs in the replication cohort are indicated in bold type. a indicates has a secondary signal. The 
secondary signal at DPT, rs761499672, was located 379 Kb away from the lead SNV, rs607484, 
while the secondary signals at SCN5A-SCN10A, rs6797133 and rs6801957, were located 54 Kb 
and 57 Kb, respectively, away from the lead SNV (rs7373065); and the secondary signal at LITAF, 
rs570620219, was located 40Kb away from the lead SNV (rs2080512). b Lead SNV is in moderate 
























































































































































































































































































































































Table 2: Discovery, replication, and full GWAS results for the lead SNVs for Tpe dynamics 
during exercise. Abbreviations: SNV: single-nucleotide variation, CHR: Chromosome, BP: 
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Position, based on HG build 19, EA: Effect allele, AA: Alternate allele, EAF: Effect allele frequency 
from discovery data, β: Beta, SE: Standard Error, N: number of participants, P: P-value. The locus 
name indicates the gene that is in the closest proximity to the most associated SNV. Replicated 










































































































































































































































Table 3: Discovery, replication, and full GWAS results for the lead SNV for Tpe dynamics 
during recovery. Abbreviations: SNV: single-nucleotide variation, CHR: Chromosome, BP: 
Position, based on HG build 19, EA: Effect allele, AA: Alternate allele, EAF: Effect allele frequency 
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from discovery data, β: Beta, SE: Standard Error, N: number of participants, P: P-value. The locus 
name indicates the gene that is in the closest proximity to the most associated SNV. 
 
